Two Sigma Advisers
ELOX

Two Sigma Advisers’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Two Sigma Advisers’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,233
Closed -$13K – 2806
2022
Q2 		$13K Sell
1,233
-4,602
-79% -$63.5K ﹤0.01% 2580
2022
Q1 		$131K Sell
5,835
-5,865
-50% -$115K ﹤0.01% 2459
2021
Q4 		$331K Sell
11,700
-5,933
-34% -$259K ﹤0.01% 2109
2021
Q3 		$1.15M Buy
17,633
+12,020
+214% +$741K ﹤0.01% 1548
2021
Q2 		$447K Buy
+5,613
New +$468K ﹤0.01% 1986

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Advisers's ELOX Position: Q3 2022 in Review

Two Sigma Advisers sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2022, closing a stake of 1,233 shares — an estimated $13K sold.

Two Sigma Advisers first reported a position in ELOX in Q2 2021 and held it in 5 quarters. The position peaked at $1.15M in Q3 2021. 30 funds tracked by Wall St. Rank hold ELOX as of Q3 2022.

  • Two Sigma Advisers reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 1,233 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $13K.
  • Two Sigma Advisers first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Two Sigma Advisers's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $1.15M in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.